In vivo reprogramming of pathogenic lung TNFR2 + cDC2s by IFNβ inhibits HDM-induced asthma-Reference-Cited by-同舟云学术

In vivo reprogramming of pathogenic lung TNFR2 + cDC2s by IFNβ inhibits HDM-induced asthma

Author:

Mansouri Samira¹,Gogoi Himanshu¹,Pipkin Mauricio²,Machuca Tiago N.²^ORCID,Emtiazjoo Amir M.¹,Sharma Ashish K.³^ORCID,Jin Lei¹^ORCID

Affiliation:

1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL 32610, USA.

2. Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Florida, Gainesville, FL 32610, USA.

3. Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Florida, Gainesville, FL 32610, USA.

Abstract

The IFNβ-ERK2-FAO pathway promotes tolerance in lung TNFR2 + cDC2s.

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference41 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献